Lagatar24 Desk   New Delhi, July 8: More affordable versions of the popular medication Januvia (Sitagliptin) went on sale on Wednesday and more are on the way, according to the latest reports. With the arrival of generic versions of US company Merck’s top-selling diabetic medication Januvia, which would cut the cost of treatment by a … Continue reading Sitagliptin goes off-patent, diabetes therapy cost to reduce by third